LauraL.WorthMD
Pediatric Hematology & Oncology • Houston, TXAssociate Professor, University of Texas Medical School at Houston
Dr. Worth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd Unit 87
Houston, TX 77030Phone+1 713-792-7751Fax+1 713-794-5042
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1998- University of Texas Health Science Center at HoustonResidency, Pediatrics, 1990 - 1994
McGovern Medical School at UTHealthClass of 1990
Certifications & Licensure
TX State Medical License 1991 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Start of enrollment: 2005 Oct 01
- Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma Start of enrollment: 2007 Oct 01
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies Start of enrollment: 2009 Mar 02
- Join now to see all
Publications & Presentations
PubMed
- 342 citationsCord-blood engraftment with ex vivo mesenchymal-cell coculture.Marcos de Lima, Ian McNiece, Simon N. Robinson, Mark F. Munsell, Mary Eapen
The New England Journal of Medicine. 2012-12-12 - 77 citations9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in miceNadezhda V. Koshkina, Eugenie S. Kleinerman, Clifford Waldrep, Shu Fang Jia, Laura L. Worth
Clinical Cancer Research. 2000-07-01 - 53 citationsFludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsBorje S. Andersson, Peter F. Thall, Ben C. Valdez, Denái R. Milton, Gheath Alatrash
Bone Marrow Transplantation. 2017-04-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
